Aperiam Bio Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
5
Aperiam Bio General Information
Description
Operator of a protein engineering company intended to improve the thermal and mechanical stress tolerance of the chemical. The company utilizes computer vision algorithms and deep learning optimization to illuminate critical parts of chemistry to identify gain-of-function mutations to engineer biological molecules for agricultural and pharmaceutical applications, enabling researchers to develop proteins that are more effective and durable.
Contact Information
Website
www.aperiambio.comCorporate Office
- 99 Washington Avenue
- Suite 805A
- Albany, NY 12210
- United States
Corporate Office
- 99 Washington Avenue
- Suite 805A
- Albany, NY 12210
- United States
Aperiam Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Seed Round | 29-Nov-2023 | Completed | Generating Revenue |
Aperiam Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed Plus | ||||||||
| Seed-1 | ||||||||
| Seed | 2,024,361 | $0.000010 | $2.2 | $2.2 | 1x | $2.2 | 7.6% |
Aperiam Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aperiam Bio Patents
Aperiam Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025072768-A1 | Alcohol cleansing methods | Inactive | 28-Sep-2023 | ||
| WO-2025072636-A1 | Degradation of toxin in vivo | Inactive | 28-Sep-2023 |
Aperiam Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aperiam Bio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Axial (San Francisco) | Venture Capital | Minority | ||
| Civilization Ventures | Venture Capital | Minority | ||
| KdT Ventures | Venture Capital | Minority | ||
| OMX Ventures | Venture Capital | Minority | ||
| Texas Innovation Center | Accelerator/Incubator |
Aperiam Bio FAQs
-
When was Aperiam Bio founded?
Aperiam Bio was founded in 2018.
-
Where is Aperiam Bio headquartered?
Aperiam Bio is headquartered in Albany, NY.
-
What is the size of Aperiam Bio?
Aperiam Bio has 5 total employees.
-
What industry is Aperiam Bio in?
Aperiam Bio’s primary industry is Biotechnology.
-
Is Aperiam Bio a private or public company?
Aperiam Bio is a Private company.
-
What is Aperiam Bio’s current revenue?
The current revenue for Aperiam Bio is .
-
How much funding has Aperiam Bio raised over time?
Aperiam Bio has raised $9M.
-
Who are Aperiam Bio’s investors?
Axial (San Francisco), Civilization Ventures, KdT Ventures, OMX Ventures, and Texas Innovation Center have invested in Aperiam Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
